Table: Hisamitsu -2024/25 group results

Hisamitsu Pharmaceutical Co

10/04/2025 07:30

Apr 10 (Reuters)- 
          Hisamitsu Pharmaceutical Co Inc 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Feb 28, 2025    Feb 29, 2024   Feb 28, 2026     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            156.01          141.71         165.00                 
                 (+10.1 pct)     (+10.4 pct)    (+5.8 pct)               
  Operating         18.90           13.17          20.00                 
                 (+43.5 pct)     (+13.5 pct)    (+5.8 pct)               
  Recurring         24.01           19.65          24.30                 
                 (+22.2 pct)     (+22.4 pct)    (+1.2 pct)               
  Net
  Net               21.76           13.97          22.00                 
                 (+55.8 pct)     (+19.0 pct)    (+1.1 pct)               
  EPS            295.57 yen      181.62 yen     298.86 yen               
  EPS Diluted    295.15 yen      181.42 yen                              
  Ann Div         90.00 yen       85.00 yen     120.00 yen               
  -Q2 Div         45.00 yen       42.50 yen      60.00 yen               
  -Q4 Div         45.00 yen       42.50 yen      60.00 yen               
  
  NOTE - Hisamitsu Pharmaceutical Co Inc.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T